Tactile Systems Technology Q3 Revenue Grows 7% Amid Rising Expenses and Airway Clearance Slump
Tactile Systems Technology (TCMD) reported third-quarter revenue of $91.9 million, a 7% increase year-over-year, driven by double-digit growth in its core lymphedema business. However, net income declined to $7.2 million from $8.2 million as sales and administrative expenses outpaced revenue gains. The company's airway clearance segment saw a significant 25% revenue drop, which management attributed to inventory transitions following the launch of a new AffloVest model. Despite the earnings miss causing an 8% drop in after-hours trading, management maintained its 2026 revenue outlook and slightly raised its adjusted EBITDA forecast. Investors remain focused on whether the company can stabilize operating expenses and if airway clearance sales will rebound in the fourth quarter as suppliers restock new inventory.
Tickers: $TCMD
Topics: net income decline operating expenses revenue growth segment performance
Read the full article at Motley Fool
Part of the story Tactile Systems Technology Q3 Revenue Grows 7% Amid Rising Expenses and Airway Clearance Slump (7 articles)